Description:

RTOG 0825 Phase III GBM Code Breaking Form (CX) Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AE1E7F4-0A01-483F-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AE1E7F4-0A01-483F-E044-0003BA3F9857

Keywords:
Versions (2) ▾
  1. 8/26/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00884741 Transmittal - RTOG 0825 Phase III GBM Code Breaking Form (CX) - 2797360v1.0

No Instruction available.

  1. StudyEvent: RTOG 0825 Phase III GBM Code Breaking Form (CX)
    1. No Instruction available.
Module 1
Amended Data (INSTRUCTIONS: Complete form on web to unblind the protocol treatment arm)
Recurrence Or Progression
Has the patient been diagnosed with first recurrence or progression (MUST BE DIAGNOSED BY IMAGING ONLY)
Contact Information For Treating Physician
Footer Module